These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9932414)

  • 1. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases.
    Braak H; de Vos RA; Jansen EN; Bratzke H; Braak E
    Prog Brain Res; 1998; 117():267-85. PubMed ID: 9932414
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropathological substrate of dementia in Parkinson's disease.
    Jellinger K
    Ann Neurol; 1990 Nov; 28(5):723-4. PubMed ID: 2260863
    [No Abstract]   [Full Text] [Related]  

  • 3. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.
    Caviness JN; Beach TG; Hentz JG; Shill HA; Driver-Dunckley ED; Adler CH
    Clin EEG Neurosci; 2018 Sep; 49(5):321-327. PubMed ID: 29161906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal communication breakdown in neurotransmitter systems in Alzheimer's and Parkinson's dementias.
    Chan-Palay V
    J Neurocytol; 1990 Oct; 19(5):802-6. PubMed ID: 1706418
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mental time dysfunction in Parkinson's and Alzheimer's diseases].
    Honma M; Kuroda T; Futamura A; Sugimoto A; Kawamura M
    Brain Nerve; 2015 Mar; 67(3):297-302. PubMed ID: 25846444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
    Ebmeier KP; Besson JA; Cherryman G; Smith F
    Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
    Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):972-5. PubMed ID: 1800669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuropathologic substrate of Parkinson disease dementia.
    Jellinger KA
    Acta Neuropathol; 2010 Jan; 119(1):151-3. PubMed ID: 19924423
    [No Abstract]   [Full Text] [Related]  

  • 11. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinson's disease accompanied by dementia--a case of concurrent Parkinson's and Alzheimer's diseases (author's transl)].
    Sugimura K; Yamasaki Y; Ando K
    Rinsho Shinkeigaku; 1977 Aug; 17(8):513-9. PubMed ID: 923169
    [No Abstract]   [Full Text] [Related]  

  • 13. The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic.
    Strobel G
    J Alzheimers Dis; 2009; 18(3):625-40. PubMed ID: 19749400
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropathology of cigarette smoking.
    Chang RC; Ho YS; Wong S; Gentleman SM; Ng HK
    Acta Neuropathol; 2014 Jan; 127(1):53-69. PubMed ID: 24240736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.
    Bancher C; Braak H; Fischer P; Jellinger KA
    Neurosci Lett; 1993 Nov; 162(1-2):179-82. PubMed ID: 8121624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.
    Hoozemans JJ; van Haastert ES; Nijholt DA; Rozemuller AJ; Scheper W
    Neurodegener Dis; 2012; 10(1-4):212-5. PubMed ID: 22302012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.
    Askanas V; Engel WK
    Acta Neuropathol; 2008 Dec; 116(6):583-95. PubMed ID: 18974994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary to "Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease".
    Mandal PK; Pettegrew JW
    Neurochem Res; 2008 Jun; 33(6):1168. PubMed ID: 18049892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.